SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Rande Is . . . HOME
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: GREENLAW4-7 who wrote (46571)2/3/2001 4:51:11 PM
From: DlphcOracl  Read Replies (2) of 57584
 
greenlaw4-7: I think biotechs will be like the internet, all right, although not quite in the way you imagine. While they had a stellar run last year, I think investors are no longer willing to chase them up to higher levels on the promise of products 3-5 years away, at best. The biotechs will be this year's version of 2000's internets -- many have and will continue to sell off dramatically without ever recovering.

The only biotech winners will be those larger companies with well established products already in the marketplace (AMGN, DNA, IMNX), those companies with a multi-drug pipeline of drugs in Phase III trials, and the picks-and shovel companies (ABSC, PKI, WAT) that all biotech companies buy from.

This is a good sector to avoid this year, IMO.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News